Fully automated platform for determination of Benzodiazepines in serum

Significance of the topic

Benzodiazepines represent one of the most commonly prescribed classes of psychoactive drugs, with applications in anxiety relief, sedation and seizure control. Their narrow therapeutic window and variable pharmacokinetics demand precise therapeutic drug monitoring (TDM) to optimize dosing, ensure patient compliance and minimize adverse effects. Highly sensitive and specific analytical techniques are essential for accurate quantification of these compounds in biological samples.

Objectives and study overview

This study aimed to develop and validate a fully automated platform for the quantification of a broad panel of benzodiazepines and related hypnotics in human serum. By integrating sample preparation and LC–MS/MS analysis, the workflow sought to reduce operator intervention, enhance throughput and improve data quality for routine clinical and research settings.

Methodology and materials

Serum samples, calibrators and internal standard mixtures were obtained from a standardized TDM kit. The CLAM-2000 automatic preparation unit performed protein precipitation and filtration steps directly online with a Nexera X2 HPLC system and an LCMS-8060 triple quadrupole mass spectrometer. Chromatographic separation was achieved on a phenyl-diazepine–optimized column over a 7.5-minute binary gradient at 40 °C with a 0.6 mL/min flow rate. Multiple reaction monitoring (MRM) in positive electrospray ionization mode ensured selective quantification.

Instrumentation used

• CLAM-2000 automated sample preparation unit
• Shimadzu Nexera X2 HPLC system
• Shimadzu LCMS-8060 triple quadrupole mass spectrometer
• ClinMass® TDM Kit System and reference serum controls

Main results and discussion

The fully automated workflow delivered a throughput of one complete benzodiazepine panel result every eight minutes. Calibration curves for all analytes exhibited excellent linearity (R² values above 0.996) across clinically relevant concentration ranges. Accuracy fell within 85–115% limits, and intra- and interday precision CVs remained below typical acceptance criteria. The elimination of manual pipetting steps improved reproducibility and traceability throughout the analytical process.

Benefits and practical applications of the method

The integrated automation streamlines sample handling, reduces the risk of operator-induced errors and lowers reagent consumption. This approach enhances laboratory productivity and supports high-throughput TDM workflows in clinical, forensic and pharmaceutical research laboratories.

Future trends and potential applications

Advancements may include expansion to additional drug panels, incorporation of on-line data analysis software, and coupling with machine learning algorithms for real-time decision support. Miniaturized and multiplexed platforms could further increase throughput and facilitate decentralized or point-of-care monitoring applications.

Conclusion

This fully automated LC–MS/MS platform offers a robust, efficient and reproducible solution for therapeutic monitoring of benzodiazepines in serum. By integrating sample preparation and analysis, it meets the demands of routine high-throughput laboratories, ensuring accurate dosing guidance and improved patient safety.